Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP502270.RAyLZTbU-Gnh8q-fpEsciU_Eua6AcnvHbv0aNEitqdfbo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502270.RAyLZTbU-Gnh8q-fpEsciU_Eua6AcnvHbv0aNEitqdfbo130_assertion type Assertion NP502270.RAyLZTbU-Gnh8q-fpEsciU_Eua6AcnvHbv0aNEitqdfbo130_head.
- NP502270.RAyLZTbU-Gnh8q-fpEsciU_Eua6AcnvHbv0aNEitqdfbo130_assertion description "[Interestingly, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, and CXCL8 chemokines were present at higher levels in metastases when compared with grade I and III biopsies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502270.RAyLZTbU-Gnh8q-fpEsciU_Eua6AcnvHbv0aNEitqdfbo130_provenance.
- NP502270.RAyLZTbU-Gnh8q-fpEsciU_Eua6AcnvHbv0aNEitqdfbo130_assertion evidence source_evidence_literature NP502270.RAyLZTbU-Gnh8q-fpEsciU_Eua6AcnvHbv0aNEitqdfbo130_provenance.
- NP502270.RAyLZTbU-Gnh8q-fpEsciU_Eua6AcnvHbv0aNEitqdfbo130_assertion SIO_000772 18045955 NP502270.RAyLZTbU-Gnh8q-fpEsciU_Eua6AcnvHbv0aNEitqdfbo130_provenance.
- NP502270.RAyLZTbU-Gnh8q-fpEsciU_Eua6AcnvHbv0aNEitqdfbo130_assertion wasDerivedFrom befree-20150227 NP502270.RAyLZTbU-Gnh8q-fpEsciU_Eua6AcnvHbv0aNEitqdfbo130_provenance.
- NP502270.RAyLZTbU-Gnh8q-fpEsciU_Eua6AcnvHbv0aNEitqdfbo130_assertion wasGeneratedBy ECO_0000203 NP502270.RAyLZTbU-Gnh8q-fpEsciU_Eua6AcnvHbv0aNEitqdfbo130_provenance.